Accountant - Temporary to Permanent at Abata Therapeutics

Seattle, Washington, United States

Abata Therapeutics Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

  • 3-5+ years of accounting experience with life sciences/lab environment required, biotech startup strongly preferred
  • BA, BS in accounting or equivalent combination of education and experience required
  • CPA Certification a plus
  • Experience with Bill.com, Netsuite and Netsuite Planning & Budgeting (or similar systems) and credit card management systems required
  • Experience with Quartzy (or other procurement systems) required
  • Familiarity with Washington State Sales and Use Tax required
  • Detail oriented, reliable, and able to interact with employees and vendors in a professional manner
  • Comfortable in a fast-paced and collaborative environment
  • Proficiency in Google Suite (docs, sheets, slides, gmail) & MS Office Suite (Word, Excel)

Responsibilities

  • Execute general Ledger accounting and month-end, quarter-end, year-end close processes, including preparing journal entries, reconciling accounts, monthly accruals, fixed asset management and variance analysis
  • Operate AP / AR processes, including invoice review, coding, 3-way match and payment processing
  • Administer POs, and related coding, expense, prepaids and accruals
  • Manage company credit card transactions, expense reports and related reconciliations
  • Investigate and resolve accounting discrepancies
  • Serve as primary Accounting point of contact for internal and external inquiries and discrepancy resolution
  • Support Financial Audits and Federal, State, Local tax returns and other government filings
  • Execute 1099 processing and maintenance
  • Maintain files and documentation in accordance with company policy and GAAP
  • Uphold internal controls and influence process improvements
  • Serve as backup for Purchasing through our Procurement administration system
  • Work on adhoc projects to support the financial health, compliance and general administrative operations of Cajal
  • Champion a culture of nimbly leaning in to meet business needs as part of our general administrative ops team

Skills

General Ledger
Month-End Close
Journal Entries
Account Reconciliation
Accruals
Fixed Asset Management
Variance Analysis
Accounts Payable
Accounts Receivable
Invoice Processing
PO Management
Expense Reports
Credit Card Reconciliation
Financial Audits
Tax Filings
1099 Processing
GAAP
Internal Controls

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI